Advisor Group, Inc. - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q4 2019$12,000
+9.1%
1000.0%0.00%
Q3 2019$11,000
+10.0%
1000.0%0.00%
Q2 2019$10,000
+11.1%
1000.0%0.00%
Q1 2019$9,000
-10.0%
100
-23.1%
0.00%
Q4 2018$10,000
+25.0%
130
+30.0%
0.00%
Q3 2018$8,000
-20.0%
1000.0%0.00%
Q2 2018$10,000
-9.1%
100
-30.1%
0.00%
Q1 2018$11,000
+10.0%
143
+15.3%
0.00%
Q4 2017$10,0000.0%124
+6.9%
0.00%
Q3 2017$10,0001160.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
Kite Lake Capital Management (UK) LLP 207,382$24,135,00076.46%
Maso Capital Partners Ltd 539,597$62,798,00020.20%
York Capital Management Global Advisors, LLC 1,102,163$128,270,0007.40%
HHLR ADVISORS, LTD. 2,751,200$320,185,0003.99%
Dalton Investments, Inc. 15,551$1,810,0001.14%
Athos Capital Ltd 8,290$965,0000.96%
Myriad Asset Management Ltd. 67,019$7,799,0000.94%
Temasek Holdings (Private) Ltd 990,000$115,216,0000.75%
OXFORD ASSET MANAGEMENT LLP 211,646$24,631,0000.68%
AGF Investments America Inc. 12,230$1,423,0000.47%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders